The Form 4 filing, a report of an insider's stock activity, was filed on November 2, 2026. The purchase took place on that same date.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-02 |
| Date of Latest Transaction | 2026-11-02 |
| Buy/Sell | buy |
| Transaction Count | 1 |
| Shares Transacted | 375,000 |
| Price | $16.00 |
| Total Transaction Value | $6,000,000.00 |
| Insider | |
| Ticker Symbol | BBTX |
| Company | Bambusa Therapeutics, Inc. |
| Insider Name | Jeggle Helmut Wolfgang |
| Insider Title | Director, 10% Owner |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 9,264,301 |
| Position Size Change | 4.05% |
| Filing | |
| Filing Date | 2026-11-02 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share purchase by Helmut Wolfgang Jeggle, a director and 10% owner of Bambusa Therapeutics, Inc. (BBTX). The record lists one transaction with code P, which identifies a purchase. The available details do not state where the shares were bought.
What was the average price of the transaction?
The average price was $16.00 per share. That price applies to the single reported purchase of 375,000 shares.
How did this transaction affect the insider's holdings?
Helmut Wolfgang Jeggle bought 375,000 shares and reported owning 9,264,301 shares afterward. The purchased shares made up 4.05% of that reported total.
What's the total transaction value?
The total transaction value was $6,000,000.00 for the one reported purchase. That amount covers all 375,000 shares bought at an average price of $16.00 each.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for this purchase. Filing footnote text was not available, so any further terms or explanations in those notes remain unknown.
For research purposes only; not investment advice.